[ET Net News Agency, 12 June 2026] HANSOH PHARMA (03692) rose 2.9% to HK$30.08.
It hits an intra-day high of HK$30.14, breaking above the 10-D SMA of HK$29.758, and an intra-day low of HK$28.96. The total shares traded was 4.29 million, with a value of HK$126.36m. The active buy/sell ratio is 58:42, with net buying turnover of HK$20.02m. MACQUARIE CAPITAL accounts for greatest net responsive buying turnover of HK$9.39m, with volume weighted average price of HK$29.327. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$4.94m, with volume weighted average price of HK$29.425.
The Hang Seng Index now rose 488 points, or 2% to 24,737; the Hang Seng China Enterprises Index now rose 164 points, or 2% to 8,381.
Basic Information| Nominal | 30.080 | % Chg | +2.94% |
| High | 30.140 | Low | 28.960 |
| Shares Tr | 4.29m | Turnover | 126.36m |
| 10-D SMA | 29.758 | %H.V | 30.689 |
| 20-D SMA | 31.646 | VWAP | 29.480 |
| 50-D SMA | 35.337 | RSI14 | 34.523 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 58:42, with net buying turnover of HK$20.02m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 30.08 | +2.94 |
| SIHUAN PHARM (00460) | 0.94 | +2.17 |
| GRAND PHARMA (00512) | 5.05 | +3.46 |
| SBP GROUP (01177) | 4.73 | +6.05 |
| HENGRUI PHARMA (01276) | 55.10 | +4.85 |
| LIVZON PHARMA (01513) | 27.00 | +2.12 |
| LUYE PHARMA (02186) | 1.92 | +2.67 |
| FOSUN PHARMA (02196) | 16.45 | +2.24 |
| SH PHARMA (02607) | 11.88 | +2.24 |
| CHINARES PHARMA (03320) | 4.86 | +1.25 |
(ed)
